These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8483292)

  • 1. Effects of BMY-21502 on anoxia in mice.
    Amano M; Goto A; Takahashi N; Hasegawa T; Nabeshima T
    Jpn J Pharmacol; 1993 Mar; 61(3):157-63. PubMed ID: 8483292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological studies on sufoxazine (Y-8894). (II). Anti-anoxic effect].
    Izumi N; Yasuda H
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):323-8. PubMed ID: 4085932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of R(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia.
    Ono S; Kitamura K; Maekawa M; Hirata K; Ano M; Ukai W; Yamafuji T; Narita H
    Jpn J Pharmacol; 1993 May; 62(1):81-6. PubMed ID: 8101887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of hachimi-jio-gan, an oriental herbal medicinal mixture, against cerebral anoxia.
    Hirokawa S; Nose M; Amagaya S; Oyama T; Ogihara Y
    J Ethnopharmacol; 1993 Dec; 40(3):201-6. PubMed ID: 8145576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of DM-9384, a novel pyrrolidone derivative, against experimental cerebral anoxia.
    Sakurai T; Hatanaka S; Tanaka S; Yamasaki T; Kojima H; Akashi A
    Jpn J Pharmacol; 1990 Sep; 54(1):33-43. PubMed ID: 2273646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
    Terleckyj I; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.
    Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E
    Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray, NMR, and theoretical studies of the nootropic agent BMY-21502, a pyrrolidinone derivative.
    Bandoli G; Dolmella A; Nicolini M; Tisato F
    J Pharm Sci; 1994 Jun; 83(6):878-82. PubMed ID: 9120825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of kamikihi-to, a traditional Chinese medicine, against cerebral ischemia, hypoxia and anoxia in mice and gerbils.
    Nishizawa K; Inoue O; Saito Y; Suzuki A
    Jpn J Pharmacol; 1994 Mar; 64(3):171-7. PubMed ID: 8022119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of BMY 21,502 in Alzheimer disease.
    Shrotriya RC; Cutler NR; Sramek JJ; Veroff AE; Hironaka DY
    Ann Pharmacother; 1996 Dec; 30(12):1376-80. PubMed ID: 8968446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals.
    Masuda Y; Ochi Y; Ochi Y; Karasawa T; Hatano N; Kadokawa T; Okegawa T
    Eur J Pharmacol; 1986 Apr; 123(3):335-44. PubMed ID: 3013650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the cerebral effects of sabeluzole.
    Nikolov R; Scheller D; Nikolova M
    Methods Find Exp Clin Pharmacol; 1991; 13(6):385-90. PubMed ID: 1881199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological study of TJ-8007 (Tsumura-Zokumeito) (I): Protective effects of TJ-8007 against anoxic brain damage].
    Goto K; Suekawa M; Aburada M; Hosoya E
    Nihon Yakurigaku Zasshi; 1987 Jun; 89(6):355-63. PubMed ID: 3623336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of idebenone against hypoxia in mice.
    Kiyota Y; Miyamoto M; Nagaoka A
    Arch Gerontol Geriatr; 1989 May; 8(3):241-6. PubMed ID: 2764641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role of endogenously formed cerebral prostaglandins in the development of adaptive protection against cerebral hypoxia/ischemia in mice.
    Masuda Y; Ochi Y; Ochi Y; Kadokawa T
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):721-7. PubMed ID: 3448451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological study of nicergoline. (I): Protective effect against anoxic brain damages in animals].
    Shintomi K; Egou H; Tanaka T; Itakura T; Yoshimoto K; Matsumoto M; Matsuoka Y
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):445-56. PubMed ID: 3013737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders.
    Gillis JC; Benefield P; McTavish D
    Drugs Aging; 1994 Aug; 5(2):133-52. PubMed ID: 7981485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's disease.
    Cutler NR; Shrotriya RC; Sramek JJ; Veroff AE; Seifert RD; Reich LA; Hironaka DY
    Ann N Y Acad Sci; 1993 Sep; 695():332-6. PubMed ID: 8239308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of prostaglandins D2, E1 and I2 against cerebral hypoxia/anoxia in mice.
    Masuda Y; Ochi Y; Ochi Y; Karasawa T; Hatano N; Kadokawa T; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):282-9. PubMed ID: 3543699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of a novel imidazole derivative against cerebral anoxia.
    Yasuda H; Shuto S; Tsumagari T; Nakajima A
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):136-44. PubMed ID: 686903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.